Literature DB >> 11353419

Unusual clinical presentations in patients harboring the facioscapulohumeral dystrophy 4q35 deletion.

K J Felice1, S A Moore.   

Abstract

Facioscapulohumeral dystrophy (FSHD) is a dominantly inherited myopathy usually associated with a deletion at locus 4q35. Typically, FSHD patients present with a recognizable constellation of signs including weakness of facial, shoulder and pelvic girdle, humeral, and anterior foreleg muscles; preservation of some muscles including the deltoids; and other characteristic features including prominent scapular winging, anterior axillary folds, and horizontally positioned clavicles. We performed clinical and FSHD genetic studies on four patients with atypical clinical features who were cared for at a regional neuromuscular center. The four patients, each harboring 4q35 deletions, presented with atypical phenotypes including facial-sparing scapular myopathy, limb-girdle muscular dystrophy, distal myopathy, and asymmetric brachial weakness. This report demonstrates the expanding clinical heterogeneity in patients harboring the 4q35 deletion. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11353419     DOI: 10.1002/1097-4598(200103)24:3<352::aid-mus1005>3.0.co;2-m

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  13 in total

Review 1.  Facioscapulohumeral muscular dystrophy.

Authors:  Rabi Tawil
Journal:  Curr Neurol Neurosci Rep       Date:  2004-01       Impact factor: 5.081

2.  Isolated facial diplegia and very late-onset myopathy in two siblings: atypical presentations of facioscapulohumeral dystrophy.

Authors:  Juan J Figueroa; John E Chapin
Journal:  J Neurol       Date:  2009-10-14       Impact factor: 4.849

3.  [Facioscapulohumeral muscular dystrophy. Clinical picture, atypical forms, diagnostics, genetics].

Authors:  B Jordan; C Müller-Reible; S Zierz
Journal:  Nervenarzt       Date:  2011-06       Impact factor: 1.214

4.  Facioscapulohumeral muscular dystrophy presenting with unusual phenotypes and atypical morphological features of vacuolar myopathy.

Authors:  Peter Reilich; Nicolai Schramm; Benedikt Schoser; Peter Schneiderat; Nicola Strigl-Pill; Josef Müller-Höcker; Wolfram Kress; Andreas Ferbert; Sabine Rudnik-Schöneborn; Johannes Noth; Hanns Lochmüller; Joachim Weis; Maggie C Walter
Journal:  J Neurol       Date:  2010-02-10       Impact factor: 4.849

5.  Novel diagnostic features of dysferlinopathies.

Authors:  Xiomara Q Rosales; Julie M Gastier-Foster; Sarah Lewis; Malik Vinod; Devon L Thrush; Caroline Astbury; Robert Pyatt; Shalini Reshmi; Zarife Sahenk; Jerry R Mendell
Journal:  Muscle Nerve       Date:  2010-07       Impact factor: 3.217

6.  Camptocormia phenotype of FSHD: a clinical and MRI study on six patients.

Authors:  Berit Jordan; Katharina Eger; Sabrina Koesling; Stephan Zierz
Journal:  J Neurol       Date:  2010-12-17       Impact factor: 4.849

7.  Clinical and genetic features of hearing loss in facioscapulohumeral muscular dystrophy.

Authors:  Katie L Lutz; Lenore Holte; Stephanie A Kliethermes; Carrie Stephan; Katherine D Mathews
Journal:  Neurology       Date:  2013-09-16       Impact factor: 9.910

8.  Atypical onset in a series of 122 cases with FacioScapuloHumeral Muscular Dystrophy.

Authors:  Ebe Pastorello; Michelangelo Cao; Carlo P Trevisan
Journal:  Clin Neurol Neurosurg       Date:  2011-11-12       Impact factor: 1.876

9.  Rippling muscle disease and facioscapulohumeral dystrophy-like phenotype in a patient carrying a heterozygous CAV3 T78M mutation and a D4Z4 partial deletion: Further evidence for "double trouble" overlapping syndromes.

Authors:  Giulia Ricci; Isabella Scionti; Greta Alì; Leda Volpi; Virna Zampa; Marina Fanin; Corrado Angelini; Luisa Politano; Rossella Tupler; Gabriele Siciliano
Journal:  Neuromuscul Disord       Date:  2012-01-14       Impact factor: 4.296

10.  Clinical and genetic analysis of Korean patients with facioscapulohumeral muscular dystrophy.

Authors:  Chang-Seok Ki; Seung-Tae Lee; Kyung-Sook Kim; Jong-Won Kim; Yoon-Ho Hong; Jung-Joon Sung; Kyung Seok Park; Kwang-Woo Lee
Journal:  J Korean Med Sci       Date:  2008-12-23       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.